The latest versions of these software products are being released at this week's annual meeting of MSI's Catalysis & Sorption Consortium -- a group of over thirty commercial and academic research organizations. At the meeting, MSI and Intel are introducing plans to service R&D in the chemicals industry by making MSI software available on Itanium(R), Intel's first microprocessor based on IA-64 architecture. MSI's products are being design
ed for multi-CPU Itanium based workstations and servers running Microsoft's 64-bit Windows NT operating system. The unique scientific capabilities of MSI codes will be combined with the leap forward in price/performance offered by 64-bit Itanium systems and the accessibility of a platform supported by all leading hardware vendors. MSI will work with Intel to ensure that its simulation products are available coincident with shipments of Itanium processor-based systems. "MSI's work in this area represents an excellent example of using innovative technology in the field of computational chemistry," comments Mr. Anand Chandrasekher, GM of the Workstation Products Group at Intel. "This collaboration helps us to ensure that researchers in the chemicals industry will be able to apply the power of the IA-64 architecture to practical R&D problems from the day that the Itanium(R) processor is released."
"MSI continues to push the boundaries in applying simulation to design chemical products and processes," says Dr. Michael R. Stapleton, General Manager of Materials Science at MSI. "The future addition of IA-64 DMol3 and CASTEP to our product line should provide unprecedented power and scalability to our customers. This development is consistent with our strategy of integrating our tools with industry standard software and hardware architectures."
Molecular Simulations Inc. (MSI) is a leading provider of simulation and informatics software for design and optimisation of materials and chemical systems. MSI software helps the world's foremost industrial research teams to solve commercially significant problems and accelerate product discovery and development. MSI is a subsidiary of Pharmacopeia, Inc..